Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
Department of Medicine, Division of Hematology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Blood. 2021 Jul 8;138(1):86-90. doi: 10.1182/blood.2020008118.
Mutations in the transcription factors GATA binding factor 1 (GATA1), growth factor independence 1B (GFI1B), and Runt-related transcription factor 1 (RUNX1) cause familial platelet and bleeding disorders. Mutant platelets exhibit common abnormalities including an α-granule reduction resulting in a grayish appearance in blood smears. This suggests that similar pathways are deregulated by different transcription factor mutations. To identify common factors, full platelet proteomes from 11 individuals with mutant GATA1R216Q, GFI1BQ287*, RUNX1Q154Rfs, or RUNX1TD2-6 and 28 healthy controls were examined by label-free quantitative mass spectrometry. In total, 2875 platelet proteins were reliably quantified. Clustering analysis of more than 300 differentially expressed proteins revealed profound differences between cases and controls. Among cases, 44 of 143 significantly downregulated proteins were assigned to platelet function, hemostasis, and granule biology, in line with platelet dysfunction and bleedings. Remarkably, none of these proteins were significantly diminished in all affected cases. Similarly, no proteins were commonly overrepresented in all affected cases compared with controls. These data indicate that the studied transcription factor mutations alter platelet proteomes in distinct largely nonoverlapping manners. This work provides the quantitative landscape of proteins that affect platelet function when deregulated by mutated transcription factors in inherited bleeding disorders.
转录因子 GATA 结合因子 1(GATA1)、生长因子独立性 1B(GFI1B)和 Runt 相关转录因子 1(RUNX1)的突变导致家族性血小板和出血性疾病。突变的血小板表现出常见的异常,包括α-颗粒减少,导致血涂片呈灰色外观。这表明不同转录因子突变通过相似的途径失活。为了确定共同的因素,对 11 名携带突变 GATA1R216Q、GFI1BQ287*、RUNX1Q154Rfs 或 RUNX1TD2-6 的个体和 28 名健康对照者的全血小板蛋白质组进行了无标记定量质谱分析。总共可靠地定量了 2875 种血小板蛋白质。对 300 多种差异表达蛋白的聚类分析显示病例与对照之间存在明显差异。在病例中,143 个显著下调的蛋白质中有 44 个被分配到血小板功能、止血和颗粒生物学,与血小板功能障碍和出血相一致。值得注意的是,在所有受影响的病例中,这些蛋白质都没有明显减少。同样,与对照组相比,在所有受影响的病例中,没有蛋白质普遍过表达。这些数据表明,所研究的转录因子突变以不同的、主要不重叠的方式改变血小板蛋白质组。这项工作提供了在遗传性出血性疾病中,由突变转录因子失活影响血小板功能的蛋白质的定量图谱。